Axt Inc (AXTI) · Oct 29, 2026 · Earnings
Beat — Non-GAAP EPS $0.41 vs ~$0.31 consensus; revenue $73.4M vs ~$66.0M
AXT earnings beat Q3 revenue and EPS expectations, with indium phosphide demand driving record sales and sharply higher margins.
AXT is in the middle of a rapid indium phosphide capacity ramp aimed at data-center optical connectivity and AI infrastructure demand; the prior quarter had already established a sharp growth inflection and the market was expecting roughly $66 million of Q3 revenue and $0.31 of EPS.
The quarter materially exceeded a high bar. Revenue reached a record $73.4 million, about 11% above the published consensus and above the company’s prior roughly $66 million outlook; non-GAAP EPS of $0.41 also topped the approximately $0.31 consensus. The filing says customer demand for indium phosphide drove the result.
| Q3 2026 | Q2 2026 | Q3 2025 | Consensus | |
|---|---|---|---|---|
| Revenue (Financial results) | $73.4M (+54%) | $47.6M | $28.0M | $66.0M |
| Non-GAAP gross margin (Financial results) | 56.1% | 45.0% | 22.4% | |
| GAAP diluted EPS (Financial results) | $0.39 | $0.17 | $(0.04) | |
| Non-GAAP EPS (Financial results) | $0.41 | $0.19 | $(0.03) | $0.31 |
This was more than a volume beat. Non-GAAP gross margin expanded to 56.1% from 45.0% in Q2, suggesting the capacity and productivity gains are improving the economics of the ramp rather than merely adding low-margin sales. GAAP net income also rose to $25.7 million from $11.1 million sequentially. 〔0〕
The filing strengthens the core AI-optics growth story, but does not remove execution risk. Management says it has surpassed its 2026 InP capacity-doubling goal and expanded the 2026 revenue opportunity more than fourfold, while the release still identifies export permits, China-related administrative issues and U.S.-China tensions as material uncertainties. 〔1〕
Bottom line: AXT did not merely confirm an expected rebound; it delivered a clear upside surprise in revenue, EPS and margins. The filing advances the business from an anticipated InP ramp toward evidence of a faster, more profitable scale-up, although permitting and China exposure remain unresolved execution constraints.
Q3 earnings call, October 29
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!